Simultaneous determination of unmodified sevoflurane and of its metabolite hexafluoroisopropanol in urine by headspace sorptive extraction-thermal desorption-capillary gas chromatography-mass spectrometry

被引:10
作者
Accorsi, A
Morrone, B
Benzo, M
Gandini, C
Raffi, GB
Violante, FS
机构
[1] Univ Bologna, Safety Hyg & Occupat Med Serv, I-40138 Bologna, Italy
[2] Sant Orsola Malpighi Hosp, Occupat Med Unit, I-40138 Bologna, Italy
[3] Univ Pavia, Dept Pharmaceut Chem, I-27100 Pavia, Italy
关键词
sevoflurane; hexafluoroisopropanol; biomarkers of exposure; urine; biological monitoring; headspace sorptive extraction; capillary GC-MS;
D O I
10.1016/j.chroma.2004.09.039
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Unmodified sevoflurane and its metabolite, hexafluoroisopropanol (HFIP), have both been proposed as biomarkers of exposure in post-shift urine for operating room personnel exposed to inhalation anaesthetic sevoflurane. We used headspace sorptive extraction (HSSE) and thermal desorption-capillary GC-MS to assess sensitively both compounds in the urine matrix (after a HFIP deconjugation step). In GC-MS splitless mode, calibration plots (similar to 15-650 mu g/L) were linear (r(2) > 0.9910) and the limits of detection (1 mu g/L for both biomarkers) showed increased sensitivity for HFIP with respect to the previously described headspace GC-MS method. The method was suitable for biological monitoring of both biomarkers of exposure to sevoflurane. (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:131 / 134
页数:4
相关论文
共 10 条
[1]   Enflurane as an internal standard in monitoring halogenated volatile anaesthetics by headspace gas chromatography-mass spectrometry [J].
Accorsi, A ;
Valenti, S ;
Barbieri, A ;
Raffi, GB ;
Violante, FS .
JOURNAL OF CHROMATOGRAPHY A, 2003, 985 (1-2) :259-264
[2]   Proposal for single and mixture biological exposure limits for sevoflurane and nitrous oxide at low occupational exposure levels [J].
Accorsi, A ;
Valenti, S ;
Barbieri, A ;
Raffi, GB ;
Violante, FS .
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 2003, 76 (02) :129-136
[3]   Biomonitoring of exposure to nitrous oxide, sevoflurane, isoflurane and halothane by automated GC/MS headspace urinalysis [J].
Accorsi, A ;
Barbieri, A ;
Raffi, GB ;
Violante, FS .
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 2001, 74 (08) :541-548
[4]   Sorptive sample preparation - a review [J].
Baltussen, E ;
Cramers, CA ;
Sandra, PJF .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2002, 373 (1-2) :3-22
[5]  
Baltussen E, 1999, J MICROCOLUMN SEP, V11, P737, DOI 10.1002/(SICI)1520-667X(1999)11:10<737::AID-MCS7>3.0.CO
[6]  
2-4
[7]  
Barbic F, 2003, G Ital Med Lav Ergon, V25 Suppl, P95
[8]  
Haufroid V, 2000, BIOMARKERS, V5, P141, DOI 10.1080/135475000230451
[9]   CLINICAL SEVOFLURANE METABOLISM AND DISPOSITION .1. SEVOFLURANE AND METABOLITE PHARMACOKINETICS [J].
KHARASCH, ED ;
KAROL, MD ;
LANNI, C ;
SAWCHUK, R .
ANESTHESIOLOGY, 1995, 82 (06) :1369-1378
[10]   CLINICAL SEVOFLURANE METABOLISM AND DISPOSITION .2. THE ROLE OF CYTOCHROME-P450 2E1 IN FLUORIDE AND HEXAFLUOROISOPROPANOL FORMATION [J].
KHARASCH, ED ;
ARMSTRONG, AS ;
GUNN, K ;
ARTRU, A ;
COX, K ;
KAROL, MD .
ANESTHESIOLOGY, 1995, 82 (06) :1379-1388